标题
Clinicopathological significance of CD47 expression in hepatocellular carcinoma
作者
关键词
-
出版物
JOURNAL OF CLINICAL PATHOLOGY
Volume -, Issue -, Pages jclinpath-2020-206611
出版商
BMJ
发表日期
2020-06-24
DOI
10.1136/jclinpath-2020-206611
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Association between CD47 expression, clinical characteristics and prognosis in patients with advanced non‐small cell lung cancer
- (2020) Oscar Arrieta et al. Cancer Medicine
- First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
- (2019) Branimir I. Sikic et al. JOURNAL OF CLINICAL ONCOLOGY
- Macrophages induce CD47 upregulation via IL-6 and correlate with poor survival in hepatocellular carcinoma patients
- (2019) Jing Chen et al. OncoImmunology
- Checkpoint CD47 Function On Tumor Metastasis And Immune Therapy
- (2019) Shu Lian et al. OncoTargets and Therapy
- Prognostic significance of CD47 in human malignancies: a systematic review and meta-analysis
- (2018) Hui-Jun Zhao et al. Translational Cancer Research
- Cancer immunotherapy targeting the CD47/SIRPα axis
- (2017) Kipp Weiskopf EUROPEAN JOURNAL OF CANCER
- Is CD47 an innate immune checkpoint for tumor evasion?
- (2017) Xiaojuan Liu et al. Journal of Hematology & Oncology
- Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors
- (2017) Sharareh Gholamin et al. Science Translational Medicine
- CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer
- (2016) Kipp Weiskopf et al. JOURNAL OF CLINICAL INVESTIGATION
- Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma
- (2015) Zhenyu Xiao et al. CANCER LETTERS
- Nuclear factor kappa B-mediated CD47 up-regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in mice
- (2015) Jessica Lo et al. HEPATOLOGY
- Anti-CD47 antibody suppresses tumour growth and augments the effect of chemotherapy treatment in hepatocellular carcinoma
- (2015) Jessica Lo et al. LIVER INTERNATIONAL
- Co-expression of MET and CD47 is a novel prognosticator for survival of luminal-type breast cancer patients
- (2015) Irène Baccelli et al. Oncotarget
- Blockade of CD47-mediated cathepsin S/protease-activated receptor 2 signaling provides a therapeutic target for hepatocellular carcinoma
- (2014) Terence Kin-Wah Lee et al. HEPATOLOGY
- Treatment of intermediate-stage hepatocellular carcinoma
- (2014) Alejandro Forner et al. Nature Reviews Clinical Oncology
- Cancer Immunotherapy
- (2013) J. Couzin-Frankel SCIENCE
- The CD47–SIRPα pathway in cancer immune evasion and potential therapeutic implications
- (2012) Mark P Chao et al. CURRENT OPINION IN IMMUNOLOGY
- A New Therapeutic Target for Leukemia Comes to the Surface
- (2009) David S. Ritchie et al. CELL
- Functions and molecular mechanisms of the CD47–SIRPα signalling pathway
- (2009) Takashi Matozaki et al. TRENDS IN CELL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started